The 21-Gene Recurrence Score Assay and Prediction of Chemotherapy Benefit: A Propensity Score-Matched Analysis of the SEER Database.

Choi, In Sil; Jung, Jiwoong; Kim, Byoung Hyuck; Oh, Sohee; Kim, Jongjin; Park, Jin Hyun; Park, Jeong Hwan; Hwang, Ki-Tae

Choi, In Sil; Jung, Jiwoong; Kim, Byoung Hyuck; Oh, Sohee; Kim, Jongjin; Park, Jin Hyun; Park, Jeong Hwan; Hwang, Ki-Tae.

Afiliación

Choi IS; Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul 07061, Korea.
Jung J; Department of Surgery, Seoul Medical Center, Seoul 02053, Korea.
Kim BH; Department of Radiation Oncology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul 07061, Korea.
Oh S; Medical Research Collaborating Center, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul 07061, Korea.
Kim J; Department of Surgery, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul 07061, Korea.
Park JH; Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul 07061, Korea.
Park JH; Department of Pathology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul 07061, Korea.
Hwang KT; Department of Surgery, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul 07061, Korea.

Cancers (Basel) ; 12(7)2020 Jul 08.

Article en En | MEDLINE | ID: mdl-32650374

Palabras clave

breast cancer; chemotherapy; genomic assay; mortality; observational study

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google